Home LiteratureArticle Details
PMID: 22308361 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Origins of tumor-associated macrophages and neutrophils.

Cortez-Retamozo V, Etzrodt M, Newton A, Rauch PJ, Chudnovskiy A, Berger C, Ryan RJ, Iwamoto Y, Marinelli B, Gorbatov R, Forghani R, Novobrantseva TI, Koteliansky V, Figueiredo JL, Chen JW, Anderson DG, Nahrendorf M, Swirski FK, Weissleder R, Pittet MJ

Abstract

Tumor-associated macrophages (TAMs) and tumor-associated neutrophils (TANs) can control cancer growth and exist in almost all solid neoplasms. The cells are known to descend from immature monocytic and granulocytic cells, respectively, which are produced in the bone marrow. However, the spleen is also a recently identified reservoir of monocytes, which can play a significant role in the inflammatory response that follows acute injury. Here, we evaluated the role of the splenic reservoir in a genetic mouse model of lung adenocarcinoma driven by activation of oncogenic Kras and inactivation of p53. We found that high numbers of TAM and TAN precursors physically relocated from the spleen to the tumor stroma, and that recruitment of tumor-promoting spleen-derived TAMs required signaling of the chemokine receptor CCR2. Also, removal of the spleen, either before or after tumor initiation, reduced TAM and TAN responses significantly and delayed tumor growth. The mechanism by which the spleen was able to maintain its reservoir capacity throughout tumor progression involved, in part, local accumulation in the splenic red pulp of typically rare extramedullary hematopoietic stem and progenitor cells, notably granulocyte and macrophage progenitors, which produced CD11b(+) Ly-6C(hi) monocytic and CD11b(+) Ly-6G(hi) granulocytic cells locally. Splenic granulocyte and macrophage progenitors and their descendants were likewise identified in clinical specimens. The present study sheds light on the origins of TAMs and TANs, and positions the spleen as an important extramedullary site, which can continuously supply growing tumors with these cells.

MeSH Terms
Animals Humans Macrophages/immunology Mice Neoplasms/immunology,pathology Neutrophils/immunology Spleen/immunology,pathology
Authors & Affiliations
20 authors, click to expand affiliations / ORCID
Cortez-Retamozo Virna
Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.
Etzrodt Martin
Newton Andita
Rauch Philipp J
Chudnovskiy Aleksey
Berger Cedric
Ryan Russell J H
Iwamoto Yoshiko
Marinelli Brett
Gorbatov Rostic
Forghani Reza
Novobrantseva Tatiana I
Koteliansky Victor
Figueiredo Jose-Luiz
Chen John W
Anderson Daniel G
Nahrendorf Matthias
Swirski Filip K
Weissleder Ralph
Pittet Mikael J
References (43)
43 references, click to expand
  1. Macrophage diversity enhances tumor progression and metastasis.
    Cell. 2010 Apr 2;141(1):39-51 PMID: 20371344
  2. The origin and kinetics of mononuclear phagocytes.
    J Exp Med. 1968 Sep 1;128(3):415-35 PMID: 5666958
  3. Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes.
    Cancer Res. 2010 Jul 15;70(14):5728-39 PMID: 20570887
  4. A clonogenic bone marrow progenitor specific for macrophages and dendritic cells.
    Science. 2006 Jan 6;311(5757):83-7 PMID: 16322423
  5. Physiological migration of hematopoietic stem and progenitor cells.
    Science. 2001 Nov 30;294(5548):1933-6 PMID: 11729320
  6. Tumor-associated macrophages infiltration is associated with peritumoral lymphangiogenesis and poor prognosis in lung adenocarcinoma.
    Med Oncol. 2011 Dec;28(4):1447-52 PMID: 20676804
  7. Toll-like receptors on hematopoietic progenitor cells stimulate innate immune system replenishment.
    Immunity. 2006 Jun;24(6):801-812 PMID: 16782035
  8. Tumor entrained neutrophils inhibit seeding in the premetastatic lung.
    Cancer Cell. 2011 Sep 13;20(3):300-14 PMID: 21907922
  9. Conditional expression of oncogenic K-ras from its endogenous promoter induces a myeloproliferative disease.
    J Clin Invest. 2004 Feb;113(4):528-38 PMID: 14966562
  10. Risk of cancer following splenectomy.
    Int J Cancer. 1996 May 29;66(5):611-6 PMID: 8647621
  11. Origin of dendritic cells in peripheral lymphoid organs of mice.
    Nat Immunol. 2007 Jun;8(6):578-83 PMID: 17450143
  12. Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice.
    Blood. 2008 Jun 15;111(12):5457-66 PMID: 18375791
  13. Immunological aspects of cancer chemotherapy.
    Nat Rev Immunol. 2008 Jan;8(1):59-73 PMID: 18097448
  14. Systemic endocrine instigation of indolent tumor growth requires osteopontin.
    Cell. 2008 Jun 13;133(6):994-1005 PMID: 18555776
  15. Splenectomy and subsequent mortality in veterans of the 1939-45 war.
    Lancet. 1977 Jul 16;2(8029):127-9 PMID: 69206
  16. CCR2 mediates hematopoietic stem and progenitor cell trafficking to sites of inflammation in mice.
    J Clin Invest. 2010 Apr;120(4):1192-203 PMID: 20234092
  17. Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer.
    Science. 2009 Jun 12;324(5933):1457-61 PMID: 19460966
  18. Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor.
    Immunity. 2010 Jun 25;32(6):790-802 PMID: 20605485
  19. Increase in circulating stem cells following chemotherapy in man.
    Blood. 1976 Jun;47(6):1031-9 PMID: 1276467
  20. Cancer risk after splenectomy.
    Cancer. 1995 Jan 15;75(2):577-83 PMID: 7812926
  21. Myeloid-derived suppressor cells as regulators of the immune system.
    Nat Rev Immunol. 2009 Mar;9(3):162-74 PMID: 19197294
  22. Wiskott-Aldrich syndrome: histopathologic findings in the lymph nodes and spleens of 15 patients.
    Hum Pathol. 1981 Sep;12(9):821-31 PMID: 6975749
  23. Prospective isolation of human clonogenic common myeloid progenitors.
    Proc Natl Acad Sci U S A. 2002 Sep 3;99(18):11872-7 PMID: 12193648
  24. Development of monocytes, macrophages, and dendritic cells.
    Science. 2010 Feb 5;327(5966):656-61 PMID: 20133564
  25. Immunosurveillance by hematopoietic progenitor cells trafficking through blood, lymph, and peripheral tissues.
    Cell. 2007 Nov 30;131(5):994-1008 PMID: 18045540
  26. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages.
    Nature. 2000 Mar 9;404(6774):193-7 PMID: 10724173
  27. Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy.
    Cancer Discov. 2011 Jun;1(1):54-67 PMID: 22039576
  28. Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase.
    Nat Protoc. 2009;4(7):1064-72 PMID: 19561589
  29. Microenvironmental regulation of metastasis.
    Nat Rev Cancer. 2009 Apr;9(4):239-52 PMID: 19279573
  30. Imaging in the era of molecular oncology.
    Nature. 2008 Apr 3;452(7187):580-9 PMID: 18385732
  31. The pathogenesis of splenic extramedullary hematopoiesis in metastatic carcinoma.
    Cancer. 1989 Apr 15;63(8):1539-43 PMID: 2924261
  32. Cancer-related inflammation.
    Nature. 2008 Jul 24;454(7203):436-44 PMID: 18650914
  33. Structure and function of the spleen.
    Nat Rev Immunol. 2005 Aug;5(8):606-16 PMID: 16056254
  34. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis.
    Nature. 2011 Jun 08;475(7355):222-5 PMID: 21654748
  35. Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN.
    Cancer Cell. 2009 Sep 8;16(3):183-94 PMID: 19732719
  36. Therapeutic siRNA silencing in inflammatory monocytes in mice.
    Nat Biotechnol. 2011 Oct 09;29(11):1005-10 PMID: 21983520
  37. CD34+ progenitor cells in idiopathic (primary) myelofibrosis: a comparative quantification between spleen and bone marrow tissue.
    Ann Hematol. 2002 Feb;81(2):86-9 PMID: 11907788
  38. Identification of splenic reservoir monocytes and their deployment to inflammatory sites.
    Science. 2009 Jul 31;325(5940):612-6 PMID: 19644120
  39. Distinct differentiation potential of blood monocyte subsets in the lung.
    J Immunol. 2007 Feb 15;178(4):2000-7 PMID: 17277103
  40. Blood monocytes: development, heterogeneity, and relationship with dendritic cells.
    Annu Rev Immunol. 2009;27:669-92 PMID: 19132917
  41. Immunity, inflammation, and cancer.
    Cell. 2010 Mar 19;140(6):883-99 PMID: 20303878
  42. Delayed hematopoietic development in osteopetrotic (op/op) mice.
    J Exp Med. 1993 Jan 1;177(1):237-42 PMID: 8418205
  43. Tumor-associated macrophages and survival in classic Hodgkin's lymphoma.
    N Engl J Med. 2010 Mar 11;362(10):875-85 PMID: 20220182
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
1091-6490
Published
2012-02-14
Epub
2012-00-30
Pages
2491-6
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC3289379
Subset
IM
Grants
NHLBI NIH HHS · R01 HL095612 · United States
NIAID NIH HHS · R56 AI084880 · United States
NCI NIH HHS · P50 CA086355 · United States
NINDS NIH HHS · R01 NS070835 · United States
NIAID NIH HHS · R01-AI084880 · United States
NCI NIH HHS · P50-CA86355 · United States
NIAID NIH HHS · U54-R56-AI084880 · United States
NCI NIH HHS · U54 CA126515 · United States
NINDS NIH HHS · R01 NS072167 · United States
NIAID NIH HHS · R01 AI084880 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com